EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia : a systematic review and meta‐analysis

L Roper iD, E Cameron, T Yu, N Li, M Parker, N Nassar, M Nikpour

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70210 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von L Roper und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Myositis, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid, Scleroderma, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic autoimmune rheumatic diseases (SARDs), including vasculitis, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), spondyloarthritis (SpA), Sjogrens disease (SjD) and mixed connective tissue disease (MCTD), are rare but associated with substantial morbidity and healthcare burden. Their clinical heterogeneity and diagnostic complexity pose challenges for epidemiological study.

Objective

To summarise Australian data on the incidence or prevalence of the SARDs listed above.

Methods

Scientific databases were searched in July 2024. Studies reporting SARD incidence or prevalence in the general Australian population were included. Where three or more studies of the same disease existed within a comparable population, which were not at high risk of bias (Hoy Tool), a random effects model was fitted.

Results

From 1357 publications, 58 were included, on: vasculitis (16), SLE (14), RA (10), SSc (nine), IIM (six) and SpA (three), with none on SjD or MCTD identified. Meta‐analysis was possible in ANCA‐associated vasculitis (AAV) (incidence 10.80 per million person‐years), SLE (prevalence 57.86 per 100 000), lupus nephritis (prevalence 11.20 per 100 000, incidence 1.02 per 100 000 person‐years), SSc (prevalence 25.58 per 100 000), IIM (incidence 9.96 per million person‐years) and inclusion body myositis (prevalence 27.73 per million). Data were limited for paediatric populations and specific at‐risk groups (e.g. Australians of Asian heritage).

Conclusion

Australia may have above‐average prevalence of SLE and SSc and geographic variation in SSc and AAV. Key research gaps include: (1) sparse data for non‐AAV vasculitis, RA, SpA, SjD, MCTD and children; (2) limited validated algorithms to identify SARDs in administrative health data; and (3) a need for large‐scale spatial studies to detect disease clusters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyositisLupus Erythematosus, SystemicArthritis, RheumatoidScleroderma, SystemicVasculitisSpondylarthritisHumansPrevalenceAustraliaIncidence

Stichwörter der Autor:innen

Australiaadministrative health datameta‐analysisprevalencesystematic reviewsystemic autoimmune rheumatic diseases

Autor:innen und Institutionen

  • Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Sydney Musculoskeletal Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Leeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Department of Rheumatology, Westmead, Blacktown and Auburn Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia.
  • Institute of Academic Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: L Roper

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Roper, L., Cameron, E., Yu, T., Li, N., Parker, M., Nassar, N., & Nikpour, M. (2025). Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia : a systematic review and meta‐analysis. Internal Medicine Journal. https://doi.org/10.1111/imj.70210

Vancouver

Roper L, Cameron E, Yu T, Li N, Parker M, Nassar N, et al. Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia : a systematic review and meta‐analysis. Internal Medicine Journal. 2025. doi:10.1111/imj.70210

BibTeX
@article{Roper2025,
  author = {Roper, L and Cameron, E and Yu, T and Li, N and Parker, M and Nassar, N and Nikpour, M},
  title = {Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia : a systematic review and meta‐analysis},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70210}
}
Kostenlos starten →